: +1 (646) 661-6066-
$2,000 Read More Metastatic Hepatocellular Carcinoma (HCC) – Pipeline Review, H1 2016
The report provides comprehensive information on the therapeutics under development for Metastatic Hepatocellular Carcinoma (HCC), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the de... -
$2,000 Read More Burns – Pipeline Review, H1 2016
The report provides comprehensive information on the therapeutics under development for Burns, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of ... -
$2,000 Read More Cough – Pipeline Review, H1 2016
The report provides comprehensive information on the therapeutics under development for Cough, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of ... -
$2,000 Read More Scar – Pipeline Review, H1 2016
The report provides comprehensive information on the therapeutics under development for Scar, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of t... -
$2,000 Read More Pruritus – Pipeline Review, H1 2016
The report provides comprehensive information on the therapeutics under development for Pruritus, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action ... -
$2,000 Read More Open-Angle Glaucoma – Pipeline Review, H1 2016
The report provides comprehensive information on the therapeutics under development for Open-Angle Glaucoma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacologi... -
$2,000 Read More Nasopharyngeal Cancer – Pipeline Review, H1 2016
The report provides comprehensive information on the therapeutics under development for Nasopharyngeal Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacolo... -
$2,000 Read More Thalassemia – Pipeline Review, H1 2016
The report provides comprehensive information on the therapeutics under development for Thalassemia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological acti... -
$2,000 Read More Ocular Hypertension – Pipeline Review, H1 2016
The report provides comprehensive information on the therapeutics under development for Ocular Hypertension, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacologi... -
$2,000 Read More Metastatic Adenocarcinoma of The Pancreas – Pipeline Review, H1 2016
The report provides comprehensive information on the therapeutics under development for Metastatic Adenocarcinoma of The Pancreas, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the de...
Sorry, there is no ad related to this category!
-
$4,700 Read More Autoimmune Disease Diagnostics Market Analysis By Product (Systemic, Localized, ...
Global autoimmune disease diagnostics market is expected to reach USD 14.17 billion by 2020. Growing […]
-
$1,500 Read More Hetero Drugs Limited – Product Pipeline Review – 2015
Global Markets Direct’s, ‘Hetero Drugs Limited – Product Pipeline Review – 2015’, provides an overview […]
-
$4,995 Read More Parkinson’s Disease Therapeutics in Major Developed Markets to 2021: Early Pip...
Parkinson’s Disease (PD) is a progressive, chronic neurodegenerative condition, which is currently incurable. It is […]
-
$2,000 Read More Venous Leg Ulcers (Crural ulcer) – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Venous Leg Ulcers (Crural ulcer) – Pipeline Review, H1 2016’, provides an […]
-
$2,000 Read More Botulism – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Botulism – Pipeline Review, H1 2016’, provides an overview of the Botulism […]
-
$6,995 Read More Frontier Pharma: Versatile Innovation in Oncology – Identifying and Commer...
The oncology therapy area comprises a large and diverse range of indications, encompassing virtually all […]
-
$2,000 Read More Reflux Esophagitis (Gastroesophageal Reflux Disease) – Pipeline Review, H1...
Global Markets Direct’s, ‘Reflux Esophagitis (Gastroesophageal Reflux Disease) – Pipeline Review, H1 2016’, provides an […]
-
$2,500 Read More Blepharitis Global Clinical Trials Review, H1, 2016
This report provides top line data relating to the clinical trials on Blepharitis. Report includes […]
-
$2,000 Read More Iron Deficiency Anemia – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Iron Deficiency Anemia – Pipeline Review, H1 2016’, provides an overview of […]
-
$2,000 Read More Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection – Pipeline ...
The report provides comprehensive information on the therapeutics under development for Severe Acute Respiratory Syndrome […]
